Sign in

CIK 0001053369

  • Non-accelerated filer
  • Smaller reporting company

ELITE PHARMACEUTICALS INC /NV/

Sign in to watch
Ticker
ELTP
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
NJ
Entity type
Operating
EIN
223542636
Phone
+1 201-750-2646
Business address
165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
Former names
ELITE PHARMACEUTICALS INC /DE/
Open-market buys, last 90 days
$25,980
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$25,980. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Dash Barry H +$26K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2012-02-21 EPIC INVESTMENTS, LLC 10% owner Conversion · Series E Convertible Preferred Stock −1,300 $1,000.00 $1.3M 1,812.5
2012-01-26 POTTI RAM Director Sale −407,949 $0.12 $49K 2,976,190
2011-08-12 NARINE JEENARINE Director Purchase · Series E Convertible Preferred Stock +125 $1,000.00 $125K 3,112.5
2011-08-12 POTTI RAM Director Purchase · Series E Convertible Preferred Stock +125 $1,000.00 $125K 3,112.5
2011-08-12 NIGALAYE ASHOK G Chief Scientific Officer Purchase · Series E Convertible Preferred Stock +125 $1,000.00 $125K 3,112.5
2011-08-12 EPIC PHARMA LLC 10% owner Purchase · Series E Convertible Preferred Stock +125 $1,000.00 $125K 3,112.5
2011-08-12 EPIC INVESTMENTS, LLC 10% owner Purchase · Series E Convertible Preferred Stock +125 $1,000.00 $125K 3,112.5
2011-07-06 NARINE JEENARINE Director Conversion +2,976,190 3,384,139
2011-07-06 NARINE JEENARINE Director Conversion · Series E Convertible Preferred Stock −75 $1,000.00 $75K 2,978.5
2011-07-06 NIGALAYE ASHOK G Chief Scientific Officer Conversion +2,976,190 3,384,139
2011-07-06 NIGALAYE ASHOK G Chief Scientific Officer Conversion · Series E Convertible Preferred Stock −75 $1,000.00 $75K 2,978.5
2011-07-06 POTTI RAM Director Conversion +2,976,190 3,384,139
2011-07-06 POTTI RAM Director Conversion · Series E Convertible Preferred Stock −75 $1,000.00 $75K 2,987.5
2011-07-06 EPIC PHARMA LLC 10% owner Conversion +2,976,190 2,976,190
2011-07-06 EPIC PHARMA LLC 10% owner Conversion · Series E Convertible Preferred Stock −75 $1,000.00 $75K 2,978.5
2011-07-06 EPIC INVESTMENTS, LLC 10% owner Conversion +2,976,190 2,976,190
2011-07-06 EPIC INVESTMENTS, LLC 10% owner Conversion · Series E Convertible Preferred Stock −75 $1,000.00 $75K 2,978.5
2011-06-06 POTTI RAM Director Conversion +2,976,190 3,384,139
2011-06-06 POTTI RAM Director Conversion · Series E Convertible Preferred Stock −75 $1,000.00 $75K 2,987.5
2011-06-06 NIGALAYE ASHOK G Chief Scientific Officer Conversion +2,976,190 3,384,139

Page 26 of 28 · 542 trades